Using a new PET scan to tell cancer from inflammation after radiation
Part of Cancer clinical trials.
This study uses a special PET scan to tell the difference between leftover cancer and inflammation caused by radiation in people treated for head and neck cancer. It may help doctors know if more treatment is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You have a certain type of head and neck cancer (squamous cell carcinoma).
- You have already completed a full course of radiation therapy to treat the cancer.
- You cannot be pregnant or breastfeeding.
- You have not had cancer of the upper digestive tract before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new type of PET scan can predict how well a first treatment combining chemotherapy and immunotherapy works in people with advanced non-small-cell lung cancer. It aims to help doctors choose the best treatment earlier.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This study tests whether a special PET scan (micro-PET-CT) taken just after tumor removal can help confirm that no cancer cells are left behind. It is for patients with head and neck cancers who are scheduled for surgery.
This trial tests a high-resolution PET-CT scan done during surgery to help surgeons see exactly where the cancer ends. It may help make sure all cancer is removed while saving healthy tissue.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
Hear when a new Head & Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.